Use of Corbevax approved by government panel for kids aged 5-12

The expert panel of the Drug Controller General of India has recommended granting emergency use authorisation for Biological E’s Covid -19 vaccine Corbevax for children aged between 5-12 years.

The vaccine is developed by a Hyderabad based firm Biological-E. Corbevax is India’s first indigenously developed RBD protein sub-unit vaccine against Covid-19. It has been administered to children between 12 to 14 years of age from March 16th this year.
The government has sought more data from Bharat Biotech before granting approval for use of Covaxin in children aged between 5 and 12 years.